Urologic Cancers: A Multidisciplinary Approach
The following is a sample of a typical didactic lecture series. Lectures are held on Mondays from 7:00 to throughout the academic year. All speakers are from Memorial Sloan Kettering unless otherwise noted.
Bladder Cancer
Course Director
Bernard H. Bochner, MD
Member, Department of Surgery, Urology Service
| Topics | Speaker |
|---|---|
| Urinary Tract Reconstruction | Bernard H. Bochner, MD Member, Department of Surgery, Urology Service |
| Systemic Chemotherapy for Bladder Cancer | Dean F. Bajorin, MD Member, Department of Medicine, Division of Solid Tumor Oncology |
| Minimally Invasive Surgical Approaches to Radical Cystectomy | Vincent P. Laudone, MD Associate Member, Department of Surgery, Urology Service |
| Bladder Preservation Strategies | S. Machele Donat, MD Member, Department of Surgery, Urology Service |
| Multimodality Bladder Preservation Protocols for Invasive Bladder Cancer | Marisa A. Kollmeier, MD Assistant Member, Department of Radiation Oncology |
| Management of Urethral and Ureteral Cancers | S. Machele Donat, MD Member, Department of Surgery, Urology Service |
Management Issues
Course Director
Joel Sheinfeld, MD
Deputy Chief and Director of the Education and Fellowship Program, Urology Service, Department of Surgery
| Topics | Speaker |
|---|---|
| Testicular Cancer Overview and Introduction to Low-Stage Non-Seminomatous Germ Cell Tumors | Joel Sheinfeld, MD Deputy Chief, Urology Service, Department of Surgery |
| Low-Stage Non-Seminomatous Germ Cell Tumors (cont), Postchemotherapy Management of Advanced Non-Seminomatous Germ Cell Tumors | Joel Sheinfeld, MD Deputy Chief, Urology Service, Department of Surgery |
| Postchemotherapy Management of Advanced Non-Seminomatous Germ Cell Tumors (cont)/ Retroperitoneal Lymph Node Dissection | Joel Sheinfeld, MD Deputy Chief, Urology Service, Department of Surgery |
| Retroperitoneal Lymph Node Dissection: Anatomic and Surgical Considerations |
Joel Sheinfeld, MD Deputy Chief, Urology Service, Department of Surgery |
| Management of Advanced Testicular Cancer | George J. Bosl, MD Chair, Department of Medicine, and Patrick M. Byrne Chair in Clinical Oncology |
| Management of Seminoma/Late Relapse/Refractory Germ Cell Tumors |
Darren R. Feldman, MD Brett S. Carver, MD |
| Pathology of Testis Cancer | Satish K. Tickoo, MD Member, Department of Pathology |
| Risk Management | Glenn Dopf, JD, LLM Partner, Kopff, Nardelli & Dopf LLP |
| Management of Genitourinary Sarcoma | Paul Russo, MD Member, Department of Surgery, Urology Service |
| Management of Penile Cancer | Paul Russo, MD Member, Department of Surgery, Urology Service |
| Voiding Dysfunction after Radical Pelvic Surgery | Jaspreet S. Sandhu, MD Assistant Attending, Department of Surgery, Urology Service |
| Radiation Therapy Approaches–Part 2 | Michael J. Zelefsky, MD Chief, Brachytherapy Service, Department of Radiation Oncology |
| Chemotherapy and New Experimental Approaches to Advanced Prostate Cancer | Howard I. Scher, MD Chief, Genitourinary Oncology Service, Department of Medicine |
| Hormonal Therapy | Michael J. Morris, MD Associate Member, Department of Medicine |
| Non-erectile Dysfunction Sexual Problems in the Prostate Cancer Patient | John P. Mulhall, MD Member, Department of Surgery, Urology Service |
Renal Cancer
Course Director
Paul Russo, MD
Member, MSKCC Department of Surgery, Urology Service
| Topics | Speaker |
|---|---|
| Renal Cortical Tumors: Overview | Paul Russo, MD Member, Department of Surgery, Urology Service |
| Renal Cortical Tumors: Pathology | Victor E. Reuter, MD Vice Chair, Department of Pathology; Director, Immunohistochemistry Core Facility |
| Familial and Hereditary Renal Tumor Syndromes | Jonathan A. Coleman, MD Assistant Member, Department of Surgery, Urology Service |
| The Rationale for Partial Nephrectomy/Open Partial Nephrectomy | Paul Russo, MD Member, Department of Surgery, Urology Service |
| Minimally Invasive Renal Tumor Surgery | Karim A. Touijer, MD Associate Member, Department of Surgery, Urology Service |
| Treatment of Metastatic Disease | Robert J. Motzer, MD Member, Department of Medicine |